7 terminated. 7 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Terminated 7 |
| Phase 1 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow Chronic Limb-Threatening Ischemia: new trials by email Literature Review of Chronic Limb-Threatening Ischemia trials Research Report on Chronic Limb-Threatening Ischemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| YQ23 Study in Patients With Critical Limb Ischaemia YQ23, Matching placebo - Critical Limb Ischemia | Phase 1 / Phase 2 | Terminated | New Beta Innovation Limited | 5 | 2021-03-10 | 2023-12-08 |
| Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia. Autologous ASC (for Adipose-derived Stem/Stroma Cell) - Critical Limb Ischemia and Peripheral Artery Disease | Phase 2 | Terminated | University Hospital, Toulouse | 2 | 2020-03-04 | 2023-03-31 |
| Plerixafor in Diabetic Wound Healing Plerixafor, Placebo - Diabetes, Wounds | Phase 2 | Terminated | Gian Paolo Fadini | 25 | 2016-06-01 | 2019-12-19 |
| Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insulinized Diabetic Patients Type 2 With Critical Ischemia in Lower Limbs (CLI): Study of the Needs of Insulin Stem cell infusion - Critical Limb Ischemia (CLI) | Phase 1 / Phase 2 | Terminated | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 20 | 2011-09-01 | 2018-12-19 |
| A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial Disease NightHawk - Peripheral Vascular Diseases | Phase 2 | Terminated | FoxHollow Technologies | 100 | 2007-08-01 | 2008-01-18 |
| Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia Hemoglobin glutamer 250 - bovine, 6% Hydroxyethylstarch - Peripheral Vascular Disease | Phase 2 | Terminated | Biopure Corporation | 16 | 2006-05-01 | 2008-05-16 |
| Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft Remodulin (treprostinil sodium) Injection - Peripheral Vascular Disease | Phase 2 / Phase 3 | Terminated | United Therapeutics | 30 | 2003-03-01 | 2013-03-07 |
Peripheral Vascular Diseases (3) · Diabetes Mellitus (1) · Peripheral Arterial Disease (1) · Wounds and Injuries (1)
Arterial Occlusive Diseases (7) · Arteriosclerosis (7) · Atherosclerosis (7) · Cardiovascular Diseases (7) · Chronic Disease (7) · Disease Attributes (7) · Ischemia (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Vascular Diseases (7) · Peripheral Arterial Disease (6) · Peripheral Vascular Diseases (4) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1)
HBOC 201 (1) · Hydroxyethyl Starch Derivatives (1) · Injections (1) · plerixafor (1) · treprostinil (1)
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud (1) · Biopure Corporation (1) · FoxHollow Technologies (1) · Gian Paolo Fadini (1) · New Beta Innovation Limited (1) · United Therapeutics (1) · University Hospital, Toulouse (1)
United States (2) · France (1) · Hong Kong (1) · Italy (1) · South Africa (1) · Spain (1) · United Kingdom (1)
A. Gerson Greenburg, MD, Ph.D. (1) · Bernat Soria (1) · Billy Lau (1) · Gian Paolo Fadini, MD PhD (1)